![Manesh Naidu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manesh Naidu
Keine laufenden Positionen mehr
Profil
Manesh Naidu served as the General Manager-INOpulse Program at Ikaria, Inc. and as the Chief Business Officer & Vice President at Bellerophon Therapeutics, Inc. He received his undergraduate and graduate degrees from Birla Institute of Technology & Science and a graduate degree in business administration from Kellogg School of Management.
Ehemalige bekannte Positionen von Manesh Naidu
Unternehmen | Position | Ende |
---|---|---|
IKARIA, INC. | Corporate Officer/Principal | - |
BELLEROPHON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Manesh Naidu
Oklahoma State University | Graduate Degree |
Birla Institute of Technology & Science | Graduate Degree |
Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BELLEROPHON THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Ikaria, Inc.
![]() Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |